BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10095426)

  • 1. [Bone matrix production in osteosarcoma].
    Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
    Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of osteonectin in various types of osteosarcoma.
    Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
    Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of the stromal cell in giant cell tumor of bone.
    Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
    Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
    Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
    Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
    Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
    Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
    Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
    Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumours.
    Serra M; Scotlandi K; Sollazzo M; Sarti M; Maurici D; Benini S; Picci P; Bertoni F; Baldini N
    Int J Oncol; 1996 Aug; 9(2):257-61. PubMed ID: 21541509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of noncollagenous proteins and the tumor differentiation in oral maxillofacial osteosarcoma].
    Li J; He RG
    Shanghai Kou Qiang Yi Xue; 2001 Mar; 10(1):39-42. PubMed ID: 14994076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases.
    Loukopoulos P; O'Brien T; Ghoddusi M; Mungall BA; Robinson WF
    Res Vet Sci; 2004 Oct; 77(2):131-41. PubMed ID: 15196903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
    El-Badawi ZH; Muhammad EM; Noaman HH
    Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transcription factor Yin Yang 1 in human osteosarcomas.
    de Nigris F; Botti C; de Chiara A; Rossiello R; Apice G; Fazioli F; Fiorito C; Sica V; Napoli C
    Eur J Cancer; 2006 Oct; 42(15):2420-4. PubMed ID: 16962318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of extracellular matrix proteins in adenomatoid odontogenic tumor.
    Modolo F; Biz MT; Martins MT; Machado de Sousa SO; de Araújo NS
    J Oral Pathol Med; 2010 Mar; 39(3):230-5. PubMed ID: 20070486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.
    Hopyan S; Gokgoz N; Bell RS; Andrulis IL; Alman BA; Wunder JS
    J Orthop Res; 1999 Sep; 17(5):633-8. PubMed ID: 10569470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma multidisciplinary approach to the management from the pathologist's perspective.
    Raymond AK; Jaffe N
    Cancer Treat Res; 2009; 152():63-84. PubMed ID: 20213386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical examination of cytological differentiation in osteosarcomas.
    Kawakami T; Shimizu T; Kimura A; Hasegawa H; Siar CH; Ng KH; Nagatsuka H; Nagai N; Kanda H
    Eur J Med Res; 2005 Nov; 10(11):475-9. PubMed ID: 16354601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.